| Serial Number | 97705178 |
| Word Mark | GENESIS VECTOR MANUFACTURING SOLUTIONS |
| Filing Date | Tuesday, December 6, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 21, 2024 |
| Registration Number | 7393135 |
| Registration Date | Tuesday, May 21, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 31, 2023 |
| Goods and Services | Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals, plasmid DNA production; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting |
| NOT AVAILABLE | "VECTOR MANUFACTURING SOLUTIONS" |
| Goods and Services | Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research; research and development in the field of gene therapy acceleration, vector genome copy titers, droplet digital polymerase chain reaction (PCR) and digital polymerase chain reaction (PCR), mass spectrometry, capsid characterization, bioassays, plasmid DNA, and analytics testing in the field of genes and gene therapy |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 9, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | Monday, January 22, 2024 |
| First Use In Commerce Date | Monday, January 22, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 9, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, January 22, 2024 |
| First Use In Commerce Date | Monday, January 22, 2024 |
| Party Name | CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | KING OF PRUSSIA, PA 19406 |
| Party Name | CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | KING OF PRUSSIA, PA 19406 |
| Party Name | CENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | KING OF PRUSSIA, PA 19406 |
| Event Date | Event Description |
| Saturday, September 9, 2023 | ASSIGNED TO EXAMINER |
| Friday, December 9, 2022 | NEW APPLICATION ENTERED |
| Friday, December 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 18, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, September 18, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, September 18, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 20, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 11, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 31, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 31, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 26, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 6, 2024 | USE AMENDMENT FILED |
| Wednesday, April 17, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, April 18, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, May 21, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 21, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, February 6, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, February 29, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, February 29, 2024 | STATEMENT OF USE PROCESSING COMPLETE |